Mr. Lü,venture partner of Heda investment.He has over 20 years of experience in establishing and managing operations of multinational pharmaceutical companies and its joint ventures as well as 6 years of experience as a surgeon. He was Greater China President and Global Executive Committee Member of Novartis Vaccines & Diagnostics Division as well as CEO of Tianyuan Biotechnology, a Novartis JV. Prior to that, he also served in a number of senior leadership positions with GlaxoSmithKline and Nycomed. Prior to his MNC pharma-ceutical career, Dr. Lü also practiced surgery at Tongji University Hospital in Shanghai. He has solid experience in pharmaceutical production and quality control, medical registration and marketing management. Mr. Lü earned his MD Summa Cum Laude at Medical School of Southeast University Medical School in China and earned his MBA at China Europe International Business School.